BE study design issue [Design Issues]

posted by jag009  – NJ, 2019-12-13 23:26 (491 d 22:18 ago) – Posting: # 20973
Views: 2,864

Hi everyone,

Question, if one conducted a study comparing ER to an immediate release reference but not following the recommended dosage regimen of the IR. Example, as per product monograph IR is given every 4 hrs and the new ER is given every 8 hrs, but the guy designed the pk study comparing ER vs 2xIR with both give at time 0, The design is obviously wrong (due to IR dosing regimen) but would a regulatory body reject the study (assume the study pass the BE objective which is BE needed only for auc). A pivotal study not pilot.

PS, not me! Doing some due diligence..
Thx
J

Complete thread:

Activity
 Admin contact
21,419 posts in 4,475 threads, 1,508 registered users;
online 14 (0 registered, 14 guests [including 3 identified bots]).
Forum time: Sunday 22:44 CEST (Europe/Vienna)

Nothing fails like success because you do not learn anything from it.
The only thing we ever learn from is failure.
Success only confirms our superstitions.    Kenneth E. Boulding

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5